The Albus is a program whose aim is to foster the creation of a scientific network and to increase the knowledge in the use of albumin as a therapeutic product. By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.
Applications for the Albus Awards 2022 will be accepted between 01/11/2021 and 30/04/2022.
Please click here to apply.
To see the 2021 ALBUS Award winners please click here.